A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive)
Clinical trial NCT04742556 · COMPLETED
Trial details
- NCT number
- NCT04742556
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-15
- Primary completion
- 2022-10-13
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.